UK Patent Extension on HIV-treatment Drug Atripla Lost in High Court Ruling

Atripla (owned by pharmaceutical companies Merck, BMS and Gilead) is a single-tablet containing a combination of three drugs: Sustiva (efavirenz), Viread (tenofovir disoproxil fumarate) and Emtriva (emtricitabine) for use by people living with HIV.  Atripla was approved by the US… Continue Reading →

© 2020 Dawn Ellmore Employment Blog — Powered by WordPress

Theme by Anders NorenUp ↑